Related Experiment Video

Updated: Jan 4, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

24.6K

Prolonged Immunosuppression in Relapsed, Refractory Multiple Myeloma Leading to Cerebral Toxoplasmosis and

James Yeung1, Sebastiaan van Hal2, P Joy Ho3

  • 1Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

Clinical Lymphoma, Myeloma & Leukemia
|November 3, 2019
PubMed
Abstract

No abstract available in PubMed .

Keywords:
ImmunosuppressionMultiple myelomaOpportunistic infectionProgressive multifocal leukoencephalopathyToxoplasma

More Related Videos

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

6.3K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.9K

Related Experiment Videos

Last Updated: Jan 4, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
08:47

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

24.6K
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease
07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Published on: January 29, 2021

6.3K
Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice
11:25

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

13.9K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

793
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
793

Articles linked to this work by shared authors, journal, and citation graph.

Atypical infections caused by pathogenic Neisseria species N. meningitidis and N. gonorrhoeae.

Clinical microbiology reviews·2026

Persistent and pathogen-specific infection risk during long-term survivorship after CD19 chimeric antigen receptor T-cell therapy: an Australian multicentre cohort study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026

Australian Gonococcal Surveillance Program, 1 October to 31 December 2025.

Communicable diseases intelligence (2018)·2026

Infections in the First 30 Days after Chimeric Antigen Receptor T-Cell Therapy in Patients Not Receiving Fluoroquinolone Prophylaxis.

Transplantation and cellular therapy·2026

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

Blood advances·2026

Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant-Ineligible Newly Diagnosed Myeloma: An Australian Real-World, Multicenter Study.

Asia-Pacific journal of clinical oncology·2026

SOHO State of the Art Updates and Next Questions | The Evolving AML Treatment Paradigm.

Clinical lymphoma, myeloma & leukemia·2026

Comorbidity Burden and Prognosis in Patients Aged 80+ Years With Large B-Cell Lymphoma.

Clinical lymphoma, myeloma & leukemia·2026

Supportive Care in Multiple Myeloma: Evidence-Based Recommendations From the Intergroupe Francophone du Myélome (IFM).

Clinical lymphoma, myeloma & leukemia·2026

Long-Term Progression-Free Survival in Patients Treated With RVD Induction and Risk-Adapted Maintenance.

Clinical lymphoma, myeloma & leukemia·2026

Clinical Characteristics and Prognostic Analysis of Pediatric Acute Myeloid Leukemia With CBFB::MYH11: A 10-Year Single-Center Cohort Study.

Clinical lymphoma, myeloma & leukemia·2026

Efficacy and Safety of Azacitidine in Patients With RUNX1::RUNX1T1 Measurable Residual Disease-Positive Acute Myeloid Leukemia After Consolidation Therapy Who Did Not Undergo Allogeneic Hematopoietic Stem-Cell Transplantation.

Clinical lymphoma, myeloma & leukemia·2026

Recurrent In-Stent Restenosis and Accelerated Neoatherosclerosis in a Middle-Aged Woman With High Inflammatory Burden.

JACC. Case reports·2026

Perioperative B-Cell-Targeted Therapy for High-Risk Valve Surgery in Active Primary Sjögren's Disease.

JACC. Case reports·2026

Immunoglobulin G and liver stiffness in autoimmune hepatitis: Timing matters more than biochemical correction.

Clinical and translational gastroenterology·2026

Immune Landscape and Intercellular Crosstalk in the Cornea of an Autoimmune-Mediated Dry Eye Disease.

Investigative ophthalmology & visual science·2026

Gout May Mimic Infection, Even Years After Achilles Tendon Repair.

Clinical orthopaedics and related research·2026

Integrated Multiomics Profiling Reveals Membrane-Associated Signaling Alterations Associated With Disease Activity in Systemic Lupus Erythematosus.

Proteomics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us